FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113738906> ?p ?o ?g. }

• W2113738906 endingPage "372" @default.
• W2113738906 startingPage "359" @default.
• W2113738906 abstract "The concept of monoclonal antibodies (mAbs) as pharmacotherapeutics was validated in the mid-1980s with the successful clinical development of the fully murine mAb muromonab-CD3 for prevention of acute organ rejection. However, clinical applications of fully murine mAbs are restricted, owing to the high incidence of serious immune-mediated side effects, particularly upon repeated exposure. The rate and severity of immune-mediated toxicities of these agents were significantly attenuated by the development of mouse/human chimeric, fully human, and humanized mAbs. These refinements in molecular structure allowed repeated, long-term administration, where therapeutically warranted, which, in turn, broadened the scope of indications for this class of therapy. Presently, numerous mAbs are approved or are undergoing clinical evaluation for treatment of oncologic and chronic inflammatory diseases. The current experimental development landscape spans respiratory, metabolic, and central nervous system disorders as well as infectious disease. A consequence of the expanding numbers of mAb indications is concomitant administration of these agents with established small molecule pharmacotherapies, which necessitates a comprehensive understanding of mAb-small molecule drug interactions as well as mAb-mAb interactions. Current knowledge indicates that mAbs do not elicit a direct effect on the metabolic/clearance pathways for small molecular therapeutics. However, the immunomodulatory properties of mAbs can indirectly alter clearance of certain small molecule entities through the attenuation of noncatabolic enzymatic pathways." @default.
• W2113738906 created "2016-06-24" @default.
• W2113738906 creator A5031629161 @default.
• W2113738906 creator A5072855474 @default.
• W2113738906 date "2011-02-10" @default.
• W2113738906 modified "2023-10-18" @default.
• W2113738906 title "Mechanisms of Monoclonal Antibody–Drug Interactions" @default.
• W2113738906 cites W12060300 @default.
• W2113738906 cites W1505676752 @default.
• W2113738906 cites W1564161931 @default.
• W2113738906 cites W1736805871 @default.
• W2113738906 cites W1822107371 @default.
• W2113738906 cites W188303386 @default.
• W2113738906 cites W1967802139 @default.
• W2113738906 cites W1970875728 @default.
• W2113738906 cites W1977069230 @default.
• W2113738906 cites W1978059889 @default.
• W2113738906 cites W1990713809 @default.
• W2113738906 cites W1997999969 @default.
• W2113738906 cites W2005575131 @default.
• W2113738906 cites W2008960322 @default.
• W2113738906 cites W2009482238 @default.
• W2113738906 cites W2010810206 @default.
• W2113738906 cites W2012919964 @default.
• W2113738906 cites W2013191780 @default.
• W2113738906 cites W2020494888 @default.
• W2113738906 cites W2025012298 @default.
• W2113738906 cites W2026977556 @default.
• W2113738906 cites W2035610264 @default.
• W2113738906 cites W2035741632 @default.
• W2113738906 cites W2036933659 @default.
• W2113738906 cites W2041241760 @default.
• W2113738906 cites W2042988739 @default.
• W2113738906 cites W2044634578 @default.
• W2113738906 cites W2048686497 @default.
• W2113738906 cites W2049609209 @default.
• W2113738906 cites W2052067610 @default.
• W2113738906 cites W2053940836 @default.
• W2113738906 cites W2057717414 @default.
• W2113738906 cites W2061878014 @default.
• W2113738906 cites W2066865216 @default.
• W2113738906 cites W2071251390 @default.
• W2113738906 cites W2071747460 @default.
• W2113738906 cites W207907705 @default.
• W2113738906 cites W2081173055 @default.
• W2113738906 cites W2090103926 @default.
• W2113738906 cites W2092517767 @default.
• W2113738906 cites W2092839327 @default.
• W2113738906 cites W2097742807 @default.
• W2113738906 cites W2101349295 @default.
• W2113738906 cites W2103051735 @default.
• W2113738906 cites W2112271094 @default.
• W2113738906 cites W2112333205 @default.
• W2113738906 cites W2112963210 @default.
• W2113738906 cites W2116635252 @default.
• W2113738906 cites W2117195973 @default.
• W2113738906 cites W2131082981 @default.
• W2113738906 cites W2134492164 @default.
• W2113738906 cites W2142709610 @default.
• W2113738906 cites W2146813046 @default.
• W2113738906 cites W2152232379 @default.
• W2113738906 cites W2159562550 @default.
• W2113738906 cites W2167628614 @default.
• W2113738906 cites W2169911848 @default.
• W2113738906 cites W2170081256 @default.
• W2113738906 cites W2316092144 @default.
• W2113738906 cites W2424642577 @default.
• W2113738906 cites W4233568322 @default.
• W2113738906 cites W4240937321 @default.
• W2113738906 cites W92943800 @default.
• W2113738906 doi "https://doi.org/10.1146/annurev-pharmtox-010510-100510" @default.
• W2113738906 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20936946" @default.
• W2113738906 hasPublicationYear "2011" @default.
• W2113738906 type Work @default.
• W2113738906 sameAs 2113738906 @default.
• W2113738906 citedByCount "74" @default.
• W2113738906 countsByYear W21137389062012 @default.
• W2113738906 countsByYear W21137389062013 @default.
• W2113738906 countsByYear W21137389062014 @default.
• W2113738906 countsByYear W21137389062015 @default.
• W2113738906 countsByYear W21137389062016 @default.
• W2113738906 countsByYear W21137389062017 @default.
• W2113738906 countsByYear W21137389062018 @default.
• W2113738906 countsByYear W21137389062019 @default.
• W2113738906 countsByYear W21137389062020 @default.
• W2113738906 countsByYear W21137389062021 @default.
• W2113738906 countsByYear W21137389062022 @default.
• W2113738906 countsByYear W21137389062023 @default.
• W2113738906 crossrefType "journal-article" @default.
• W2113738906 hasAuthorship W2113738906A5031629161 @default.
• W2113738906 hasAuthorship W2113738906A5072855474 @default.
• W2113738906 hasConcept C159654299 @default.
• W2113738906 hasConcept C203014093 @default.
• W2113738906 hasConcept C2780035454 @default.
• W2113738906 hasConcept C542903549 @default.
• W2113738906 hasConcept C64903051 @default.
• W2113738906 hasConcept C71924100 @default.
• W2113738906 hasConcept C8891405 @default.

• next